The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics

Por How, J, Sykes, J, Minden, M D, Gupta, V, Yee, K W L, Schimmer, A D, Schuh, A C, Kamel-Reid, S, Brandwein, J M
Publicado em 2013

Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia

Por Sibai, H., Seki, J.T., Wang, T.Q., Sakurai, N., Atenafu, E.G., Yee, K.W.L., Schuh, A.C., Gupta, V., Minden, M.D., Schimmer, A.D., Brandwein, J.M.
Publicado no Curr Oncol (2016)